Stock market traders and investors often rely on technical indicators to guide their decisions. One widely used tool is the 200-day Exponential Moving Average (200-D EMA), which helps identify key price levels on a chart for both long-term investors and short-term swing traders.
What is 200-D EMA, and why is its support important?
The 200-day EMA is based on a stock’s average closing price over the previous 200 sessions, giving more weight to recent data. It is widely used to gauge the overall trend, as well as to help short-term traders identify strong support or resistance levels.
A stock that is above this level typically indicates strength and buyer interest, whereas a stock that falls below it is frequently viewed as weak. A stock trading below its 200-day EMA is generally seen as being in a bearish trend. However, this situation can also offer a potential buying opportunity if the stock indicates a reversal or appears oversold.
1. Power Grid Corporation of India Ltd
Power Grid Corporation of India Limited is a power transmission company that manages the planning, operation, and maintenance of India’s inter-state transmission network. It provides transmission, consultancy, and telecom services, including real-time monitoring through its Smart Grid, and offers expertise in design, engineering, project management, and optical fiber-based telecom solutions.
With a market capitalization of Rs. 2,65,532.24 crores on Friday, the stock closed at Rs. 285.35 per share, which is below its 200-day moving average of Rs. 294.23 in a day’s time frame. The stock is currently down by 3.08 percent from its 200-day moving average.
2. Tata Motors Ltd
Tata Motors, a prominent global automobile manufacturer based in India and a member of the Tata Group, produces a diverse range of vehicles such as passenger cars, trucks, vans, and buses. The company owns the renowned British brands Jaguar and Land Rover and is making significant investments in electric vehicles and sustainable mobility solutions.
With a market capitalization of Rs. 2,55,365.04 crores on Friday, the stock closed at Rs. 691.70 per share, which is below its 200-day moving average of Rs. 720.34 in a day’s time frame. The stock is currently down by 3.95 percent from its 200-day moving average.
3. Kotak Mahindra Bank Ltd
In February 2003, the RBI granted India’s first non-banking finance company, Kotak Mahindra Finance Ltd., a banking license, after which it became Kotak Mahindra Bank Ltd. The bank completed its merger with ING Vysya Bank in April 2015.
As of June 30, 2025, it operates 2,154 branches and 2,927 ATMs (including cash recyclers) across India, with international presence in GIFT City and Dubai’s DIFC. The bank serves both retail and corporate clients in urban and rural areas through its four main business segments: consumer banking, corporate banking, commercial banking, and treasury.
Kotak Mahindra Bank Ltd’s stock closed at Rs. 1,945.50 on Friday, with a market capitalization of Rs. 3,85,673.93 crore. It is trading 2.96 percent below its 200-day moving average of Rs. 2,005.05.
4. Shriram Finance Ltd
Shriram Finance Limited is an Indian retail non-banking finance company (NBFC) specializing in financing commercial and passenger vehicles, construction and farm equipment, two-wheelers, MSMEs, gold loans, and personal loans. It also offers fixed and recurring deposits. Its key subsidiaries are Shriram Housing Finance Limited (SHFL) and Shriram Automall India Limited (SAMIL).
With a market capitalization of Rs. 1,12,036.79 crores on Friday, the stock closed at Rs. 592.50 per share, which is below its 200-day moving average of Rs. 622.06 in a day’s time frame. The stock is currently down by 4.72 percent from its 200-day moving average.
5. Sun Pharmaceutical Industries Ltd
Sun Pharmaceutical Industries Limited is an India-based specialty generic pharmaceutical company that manufactures, develops, and markets a diverse range of branded and generic formulations as well as active pharmaceutical ingredients (APIs).
Its diverse portfolio includes chronic and acute treatments such as oncology, hormones, peptides, and steroidal drugs, as well as a wide range of dosage forms such as orals, creams, ointments, injectables, sprays, and liquids. The company also provides injectables, hospital, and retail products to Rest of World (RoW) markets.
The stock, with a market capitalization of Rs. 3,82,190.07 crore on Friday, closed at Rs. 1,593.60 per share, trading below its 200-day moving average of Rs. 1,683.28. It is currently down 5.25 percent relative to its 200-day moving average.
Written by Akshay Sanghavi
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
